Literature DB >> 21848504

mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer.

Matthias Kotzsch1, Julia Dorn, Kristina Doetzer, Barbara Schmalfeldt, Janna Krol, Gustavo Baretton, Marion Kiechle, Manfred Schmitt, Viktor Magdolen.   

Abstract

High tumor tissue mRNA expression of the tumor biological factors uPAR, uPAR-del4/5, or rab31 is associated with shorter distant metastasis-free and overall survival in breast cancer patients. To evaluate whether these factors are also clinically relevant in ovarian cancer, we quantified the respective mRNA levels in primary tumor tissue of advanced ovarian cancer patients (n=103) and evaluated their association with clinicopathological parameters and patients' prognosis. mRNA expression levels of all three markers did not show any significant association with overall or progression-free survival, demonstrating that these factors have no prognostic value in advanced ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21848504     DOI: 10.1515/BC.2011.166

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  9 in total

1.  Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway.

Authors:  Yanxia Sui; Xiaoqiang Zheng; Dongli Zhao
Journal:  Tumour Biol       Date:  2015-06-06

2.  Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells.

Authors:  Mariaevelina Alfieri; Anna Li Santi; Luigia Meo; Valentina Giudice; Carmine Selleri; Pia Ragno
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

3.  The Critical Role of Rab31 in Cell Proliferation and Apoptosis in Cancer Progression.

Authors:  Yunyan Pan; Yanling Zhang; Lijun Chen; Yan Liu; Yanlin Feng; Junyuan Yan
Journal:  Mol Neurobiol       Date:  2015-08-06       Impact factor: 5.590

Review 4.  The role of the small GTPase Rab31 in cancer.

Authors:  Christelle En Lin Chua; Bor Luen Tang
Journal:  J Cell Mol Med       Date:  2014-12-03       Impact factor: 5.310

Review 5.  Rab-mediated vesicle trafficking in cancer.

Authors:  Hong-Tai Tzeng; Yi-Ching Wang
Journal:  J Biomed Sci       Date:  2016-10-06       Impact factor: 8.410

6.  GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer.

Authors:  Xiaoqiang Zhu; Xianglong Tian; Tiantian Sun; Chenyang Yu; Yingying Cao; Tingting Yan; Chaoqin Shen; Yanwei Lin; Jing-Yuan Fang; Jie Hong; Haoyan Chen
Journal:  Mol Oncol       Date:  2018-09-28       Impact factor: 6.603

7.  Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology.

Authors:  Hexiao Shen; Li Li; Zhaowei Teng; Tianqing Meng; Xiangbin Kong; Yan Hu; Yun Zhu; Lixin Ma
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

8.  High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.

Authors:  Xiaoguang Li; Fengshuo Zhu; Zhonglong Liu; Xiao Tang; Yu Han; Junjian Jiang; Chunyue Ma; Yue He
Journal:  Oncol Rep       Date:  2021-01-18       Impact factor: 3.906

9.  Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells.

Authors:  Bettina Grismayer; Susanne Sölch; Bastian Seubert; Thomas Kirchner; Sonja Schäfer; Gustavo Baretton; Manfred Schmitt; Thomas Luther; Achim Krüger; Matthias Kotzsch; Viktor Magdolen
Journal:  Mol Cancer       Date:  2012-08-24       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.